BSD Medical Release: Hyperthermia Therapy For Recurrent Breast Cancer Added To 2007 NCCN Guidelines

SALT LAKE CITY, UT -- (MARKET WIRE) -- December 14, 2006 -- BSD Medical Corp. (AMEX: BSM) today reported that the National Comprehensive Cancer Network (NCCN) has announced that hyperthermia therapy and radiation as combination treatments are for the first time included in its 2007 Breast Cancer Guidelines for recurrent cancer of the chest wall (breast cancer) and other localized cancer recurrences. This announcement significantly supports the progressive emergence of hyperthermia therapy as a mainline therapy in the treatment of cancer. Hyperthermia therapy (heat) devices and radiation therapy devices are the only medical devices listed in the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. All other treatments are drug or hormone based.
MORE ON THIS TOPIC